The effect of non-enzymatic glycation of serum proteins on their permeation into peripheral nerve in normal and streptozotocin-diabetic rats

[1]  P. Watkins,et al.  DIABETIC NEUROPATHY: ABNORMALITIES OF SCHWANN CELL AND PERINEURIAL BASAL LAMINAE. IMPLICATIONS FOR DIABETIC VASCULOPATHY , 1989, Neuropathology and applied neurobiology.

[2]  A. Boulton,et al.  Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy , 1989, Diabetologia.

[3]  P. Dyck,et al.  Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[5]  W. Pardridge,et al.  Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. , 1987, The Journal of biological chemistry.

[6]  T. Sampietro,et al.  INCREASED PERMEABILITY OF HAMSTER MICROCIRCULATION TO GLYCOSYLATED ALBUMIN , 1987, The Lancet.

[7]  C. Kilo,et al.  Increased Vascular Permeability in Spontaneously Diabetic BB/W Rats and in Rats With Mild Versus Severe Streptozocin-Induced Diabetes: Prevention by Aldose Reductase Inhibitors and Castration , 1987, Diabetes.

[8]  S. Rapoport,et al.  Altered Blood‐Nerve Barrier Permeability to Small Molecules in Experimental Diabetes Mellitus , 1987, Journal of neuropathology and experimental neurology.

[9]  P. Dyck,et al.  Increased endoneurial albumin in diabetic polyneuropathy , 1985, Neurology.

[10]  C. Kilo,et al.  Albumin Permeation of New Vessels Is Increased in Diabetic Rats , 1985, Diabetes.

[11]  M. Bitensky,et al.  Micropinocytic ingestion of glycosylated albumin by isolated microvessels: possible role in pathogenesis of diabetic microangiopathy. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Baynes,et al.  Nonenzymatic glucosylation of rat albumin. Studies in vitro and in vivo. , 1979, The Journal of biological chemistry.

[13]  A. Sima,et al.  The perineurial and blood-nerve barriers in experimental diabetes , 1978, Acta Neuropathologica.

[14]  Y. Olsson,et al.  Permeability of the blood-nerve barrier in the streptozotocin-diabetic rat , 1978, Experimental Neurology.

[15]  F. Buchthal,et al.  Nerve biopsy and conduction studies in diabetic neuropathy. , 1977, Journal of neurology, neurosurgery, and psychiatry.

[16]  J. Vallat,et al.  Etude ultrastructurale du nerf périphérique chez 16 diabétiques sans neuropathie clinique. Comparaisons avec 16 neuropathies diabétiques et 16 neuropathies non diabétiques , 1974, Acta Neuropathologica.

[17]  K. Seneviratne.  Permeability of blood nerve barriers in the diabetic rat1 , 1972, Journal of neurology, neurosurgery, and psychiatry.

[18]  A. Bischoff.  Diabetische Neuropathie , 1968 .

[19]  S. Gray,et al.  The tagging of red cells and plasma proteins with radioactive chromium. , 1950, The Journal of clinical investigation.

[20]  R. J. Seitz,et al.  The mouse blood-brain barrier and blood-nerve barrier for IgG: A tracer study by use of the avidin-biotin system , 2004, Acta Neuropathologica.